The board of directors of Extrawell Pharmaceutical Holdings Limited announced that Mr. Xue Jing Lun, an independent non-executive Director, and a member of each of the audit committee, remuneration committee and nomination committee of the Company, passed away on 4 December 2022 due to illness. Following the passing away of Mr. Xue, the Board comprises six Directors, including four executive Directors and two independent non-executive Directors. The Company currently does not meet (i) the minimum number of independent non-executive directors required under Rule 3.10(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited; and (ii) the minimum number of members in the audit committee required under Rule 3.21 of the Listing Rules.